Theravance Biopharma Inc. (TBPH) Q1 2019 Earnings Call Transcript
TBPH earnings call for the period ending March 31, 2019.
Theravance Biopharma
TBPH
TBPH
$16.78
-$0.03
-0.2%
BATS BZX Real Time Price as of June 20, 2019, 1:09 p.m.
View Interactive TBPH Charts
Theravance Biopharma, Inc. - Ordinary Shares
News & Analysis: Theravance Biopharma
Theravance Biopharma Inc (TBPH) Q4 2018 Earnings Conference Call Transcript
TBPH earnings call for the period ending December 31, 2018.
Why Theravance Biopharma Inc Shares Tumbled 19.5% Today
Theravance Biopharma announced a stock and debt offering that disappointed investors.
Theravance Biopharma Inc Skyrocketed in October -- Here's Why
A slew of good news sends shares skyward. So what was announced that got investors so excited?
Why Theravance Biopharma Inc. Fell 20% in September
Despite releasing some good news, a rough month for biotech stocks in general crushed the company's stock.
Why Theravance Biopharma Inc Shares Soared Today
Theravance Biopharma announced that Mylan Inc. has agreed to co-develop TD-4208 and make an equity investment in the company.
This COPD Investment Opportunity Isn't What It Seems
Theravance's new structure may surprise investors looking for a pure play.
Shorts Are Piling Into These Stocks; Should You Be Worried?
Do short-sellers have these three stocks pegged? You be the judge!
